omegaven infuzní emulze - תוצאות חיפוש

צרבונין 120 מג

dr.samuelov importing & marketing ltd, israel - dry extract from ginkgo biloba leaves (35-67:1) - טבליות מצופות פילם - dry extract from ginkgo biloba leaves (35-67:1) 120 mg - ginkgo biloba

ישראל - עברית - Ministry of Health

ברונכיקליר נוזל לשתייה

dr.samuelov importing & marketing ltd, israel - fluid extract derived from ivy leaves (1:1); fluid extract derived from thyme herb (1:2-2.5) - נוזל - fluid extract derived from ivy leaves (1:1) 16.8 mg/ml; fluid extract derived from thyme herb (1:2-2.5) 168 mg/ml

ישראל - עברית - Ministry of Health

מגאקסין iv

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

ישראל - עברית - Ministry of Health

מגאקסין iv

bayer israel ltd - moxifloxacin - תמיסה לאינפוזיה - moxifloxacin 400 mg / 250 ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

ישראל - עברית - Ministry of Health

"electrodes, diathermic blades,plates "

"דובר מכשור רפואי ומדעי בע""מ" - רופא - דיאטרמיה

ישראל - עברית - Ministry of Health

accessories for operating rooms

אורטה מדיקל בע"מ - רופא - מיועד לבתי חולים,מרפאות עם חדרי ניתוח

ישראל - עברית - Ministry of Health

accessories for operating rooms

אורטה מדיקל בע"מ - רופא - מיועד לבתי חולים,מרפאות עם חדרי ניתוח

ישראל - עברית - Ministry of Health

ten20, nuprep

slp ltd. - צוות טכני - רפואת שינה